| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/18/2006 | US7030131 such as N-[4-(4-amino-1H-imidazol[4,5-c]quinolin-1-yl)butyl]-5-(dimethylamino)-naphthalenesulfonamide; for induction of biosynthesis of cytokines; immunomodulators; antineoplastic agents |
| 04/18/2006 | US7030127 Composition and medical devices utilizing bioabsorbable polymeric waxes |
| 04/18/2006 | US7030124 Method of treating depression with delta receptor agonist compounds |
| 04/18/2006 | US7030106 Ezetimibe formulation with lactose, croscarmellose sodium, povidone, sodium lauryl sulfate, magnesium stearate and microcrystalline cellulose |
| 04/18/2006 | US7030104 Topical oestroprogestational compositions with a systemic effect |
| 04/18/2006 | US7030096 transduction of DNA sequences by naked DNA transfer, expression of genes that code for muscle tone controllers; gene therapy for prophylaxis of erectile dysfunction, urogenital and muscular disorders |
| 04/18/2006 | US7030094 Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and QS-21 |
| 04/18/2006 | US7030093 Antibiotic coating for porous bodies and method for its production as well as its use |
| 04/18/2006 | US7030086 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/18/2006 | US7029986 Bonded products and methods of fabrication therefor |
| 04/18/2006 | US7029706 Composition for the treatment of cutaneous mycosis |
| 04/18/2006 | US7029701 Composition for the treatment and prevention of ischemic events |
| 04/18/2006 | US7029700 Drug delivery; dissolving in solvent, freezing, vacuum drying |
| 04/18/2006 | US7029699 Mixture containing carbohydrate and binder |
| 04/18/2006 | US7029698 Solubility characteristics for encapsulation; capsular dosage forms |
| 04/18/2006 | US7029697 Controlled surface-associated delivery of genes and oligonucleotides |
| 04/18/2006 | US7029696 Delivery and activation through liposome incorporation of diaminocyclohexane platinum(II) complexes |
| 04/18/2006 | US7029695 Therapeutic compositions containing glutathione analogs |
| 04/18/2006 | US7029694 Compositions and methods for transdermal oxybutynin therapy |
| 04/18/2006 | US7029693 Allows sustained percutaneous absorption of the drug into the body and which suppresses irritation to the skin caused by the drug |
| 04/18/2006 | US7029692 content of monoterpene ketone in the nicotine-containing layer is 0.1 to 5.0%-wt of the weight; masks the unpleasant smell of nicotine |
| 04/18/2006 | US7029678 Vaccines |
| 04/18/2006 | US7029663 substantially anhydrous, using hydrocarbon gel and/or petrolatum as a base; increased storage stability |
| 04/18/2006 | US7029659 aqueous solvent, organic cosolvent, and occlusive agent, especially petrolatum, to form an occlusive layer on the skin for the topical administration of pharmaceuticals |
| 04/18/2006 | US7029658 Delivery of antidepressants through an inhalation route |
| 04/18/2006 | US7029657 Nasal spray steroid formulation and method |
| 04/18/2006 | US7029656 Methods and formulations for the efficient delivery of water-insoluble drugs by nebulizer |
| 04/18/2006 | US7029609 Composition which can be foamed from a pressurized container for producing insulating foams |
| 04/18/2006 | US7029549 Method and device for dispensing adhesive laminate segments |
| 04/18/2006 | US7029455 Devices, systems and methods for patient infusion |
| 04/18/2006 | US7028686 Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
| 04/18/2006 | CA2409059C Stabilized aqueous suspensions for parenteral use |
| 04/18/2006 | CA2346335C Sertraline oral concentrate |
| 04/18/2006 | CA2339931C Extended release acetaminophen |
| 04/18/2006 | CA2182282C Process for preparing fine particle pharmaceutical formulations |
| 04/18/2006 | CA2173601C Liposomes containing particulate materials |
| 04/13/2006 | WO2006039692A2 Modified release ibuprofen dosage form |
| 04/13/2006 | WO2006039667A2 Water-based delivery systems |
| 04/13/2006 | WO2006039659A1 Bioadhesive delivery system for transmucosal delivery of beneficial agents |
| 04/13/2006 | WO2006039558A2 Ocular agent delivery systems |
| 04/13/2006 | WO2006039532A2 Transdermal therapeutic system for parkinson’s disease |
| 04/13/2006 | WO2006039519A1 Thermally stable, high tensile strength encapsulated actives |
| 04/13/2006 | WO2006039499A2 Method for improving the biovailability of orally delivered therapeutics |
| 04/13/2006 | WO2006039491A1 Treating morning migraines with propanolol |
| 04/13/2006 | WO2006039487A2 Sealed, edible film strip packets and methods of making and using them |
| 04/13/2006 | WO2006039460A2 Contact lens with biocidal activity, process of manufacture, use of the contact lens, and kit |
| 04/13/2006 | WO2006039459A1 Capsule for encasing tablets for surgical insertion into the human body |
| 04/13/2006 | WO2006039458A1 New viscoelastic composition, methods of use and packaging device with anti-oxidant |
| 04/13/2006 | WO2006039454A2 Technical specification editor |
| 04/13/2006 | WO2006039369A1 Microparticles and nanoparticles containing a lipopolymer |
| 04/13/2006 | WO2006039333A1 Ophthalmic drug release device for multiple drug release |
| 04/13/2006 | WO2006039330A1 Process for preparing an ocular insert containing poly (vinyl alcohol) |
| 04/13/2006 | WO2006039271A1 Process for preparing an ocular insert containing poly(vinyl alcohol) |
| 04/13/2006 | WO2006039237A1 Pharmaceutical dosage forms of stable amorphous rapamycin like compounds |
| 04/13/2006 | WO2006039129A2 Methods for making and using composites, polymer scaffolds, and composite scaffolds |
| 04/13/2006 | WO2006039022A2 Controlled regional oral delivery |
| 04/13/2006 | WO2006039014A1 Cosmetic neurotoxin compositions comprising a botulinum toxin component and methods |
| 04/13/2006 | WO2006038965A1 Skin cooling compositions |
| 04/13/2006 | WO2006038931A2 Odor-reducing quinone compounds |
| 04/13/2006 | WO2006038916A2 Scored pharmaceutical tablets comprising a plurality of segments |
| 04/13/2006 | WO2006038661A1 Medicinal composition, process for producing the same, and method of stabilizing dihydropyridine compound in medicinal composition |
| 04/13/2006 | WO2006038552A1 Composition containing fine particles and process for producing the same |
| 04/13/2006 | WO2006038528A1 Composition and method for therapy or prevention of mental symptom |
| 04/13/2006 | WO2006038226A2 Process for making a highly compressible controlled delivery compositions of metformin |
| 04/13/2006 | WO2006038080A2 Contact lens package solution |
| 04/13/2006 | WO2006037891A1 Encapsulating plant extracts adsorbed and/or absorbed in precipitated silica |
| 04/13/2006 | WO2006037771A1 Pulmonary administration of an antithrombotic compound |
| 04/13/2006 | WO2006037766A1 Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient |
| 04/13/2006 | WO2006037763A1 Oral pharmaceutical preparation for proton pump antagonists |
| 04/13/2006 | WO2006037738A1 Modifying surfaces of lactose serving as an auxiliary agent to be used for powder inhalants |
| 04/13/2006 | WO2006037736A1 Novel powder inhalation preparations based on modified lactose blends that are used as adjuvants |
| 04/13/2006 | WO2006037735A1 Device for producing a medical foam |
| 04/13/2006 | WO2006037650A1 Lercanidipine capsules |
| 04/13/2006 | WO2006037348A1 Pharmaceutical compositions comprising fenofibrate and a statin |
| 04/13/2006 | WO2006037347A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 04/13/2006 | WO2006037346A1 Pharmaceutical compositions comprising fenofibrate and simvastatin |
| 04/13/2006 | WO2006037345A1 Pharmaceutical composition comprising fenofibrate and simvastatin |
| 04/13/2006 | WO2006037344A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 04/13/2006 | WO2006037229A1 Formulation of multivalent antibody constructs and use of same for cancer therapy |
| 04/13/2006 | WO2006031658A3 Therapeutic lacrimal canalicular inserts and related methods |
| 04/13/2006 | WO2006031284A3 Covered stent with controlled therapeutic agent diffusion |
| 04/13/2006 | WO2006023684A3 Microprojection array patch for transdermal delivery of vascular endothelial growth factors |
| 04/13/2006 | WO2006018521A3 Compounds and methods for controlling alcohol intake |
| 04/13/2006 | WO2006017347A3 Opthalmic compositions and methods for treating ophthalmic conditions |
| 04/13/2006 | WO2006014973A3 Pharmaceutical dosage forms including rasagiline |
| 04/13/2006 | WO2006008401A3 Composition containing a photosynthetic marine and/or fresh-water microorganism culture medium and/or |
| 04/13/2006 | WO2005112947A3 Use of atp for the manufacture of a medicament for the prevention and treatment of oxidative stress and related conditions |
| 04/13/2006 | WO2005099763A3 Composition for intracellular transfer of a nucleic acid |
| 04/13/2006 | WO2005097077A3 Spray dried pharmaceutical compositions |
| 04/13/2006 | WO2005097063A3 Natamycin dosage form, process for preparing same, method for preserving a food product and preserved food product |
| 04/13/2006 | WO2005094798A3 Pharmaceutical compositions based on anticholinergics and ccr2 receptor antagonists |
| 04/13/2006 | WO2005082329A3 Process for the preparation of solid dosage forms of valsartan and hydrochlorthiazide |
| 04/13/2006 | WO2005070465A3 Lipid-based dispersions useful for drug delivery |
| 04/13/2006 | WO2005067893A3 Pharmaceutical compositions comprising midazolam in a high concentration |
| 04/13/2006 | WO2005063256A3 Coating method |
| 04/13/2006 | WO2005044226A3 Lipid formulations for spontaneous drug encapsulation |
| 04/13/2006 | WO2005030167A3 Buccal, polar and non-polar spray containing alprazolam |
| 04/13/2006 | WO2005013936A3 Manufacture of long term drug delivery devices with polyurethane based polymers |
| 04/13/2006 | WO2004082525A3 Sinus delivery of sustained release therapeutics |
| 04/13/2006 | US20060079862 Drug infusion device |